Abstract
OBJECTIVES: Hypertension is a major risk factor for cardiovascular diseases. Nearly one adult in four was diagnosed with hypertension in 2007–2008 in Canada. One of the objectives of this study was to determine whether the prevalence of hypertension in Quebec as assessed using administrative data is comparable to that specifically measured, especially for the elderly population.
METHODS: Trends in prevalence, incidence and mortality were examined using the Quebec Integrated Chronic Disease Surveillance System built from grouping numerous administrative databases from 1996–1997 to 2009–2010. Blood pressure measurements, hypertension prevalence, awareness and control were obtained in 1,706 Quebecers in the combined cycles of the Canadian Health Measures Survey.
RESULTS: Using administrative databases, 23.6% [95% confidence interval, 23.5–23.6] of the Quebec population (n=1,433,400) aged >20 years was diagnosed with hypertension in 2009–2010, an increase of 32.1 % compared to 2000–2001. The incidence decreased by 27.3%. Among people aged >65 years, the prevalence rose to 69.0% [95% CI: 68.8–69.2] in women and 61.7% [95% CI: 61.5–61.9] in men. For people aged 20–79 years, the prevalence of hypertension was lower with the administrative data compared to the survey (20.2% and 23.1 %, respectively). The level of awareness, treatment and control were 84.3%, 83.1% and 67.9%, respectively.
CONCLUSION: The prevalence of hypertension derived from administrative data is comparable to that obtained with a health measured survey. Elderly women (>65 years) are a very high-risk subgroup. The levels of awareness, treatment and control of hypertension in Quebec are very high.
Key words: Hypertension, public health surveillance, trends, administrative data, survey data
Résumé
OBJECTIFS: L’hypertension artérielle est un facteur de risque majeur des maladies cardiovasculaires. Près d’un adulte sur quatre a été diagnostiqué hypertendu en 2007–2008, au Canada. Un des objectifs de cette étude était de déterminer si la prévalence de l’hypertension au Québec obtenue à partir de données médico-administratives est comparable à celle mesurée, en particulier chez les personnes âgées.
METHODES: Les tendances de la prévalence, de l’incidence et de la mortalité ont été examinées avec le Système Intégré de Surveillance des Maladies Chroniques du Québec regroupant de nombreuses bases de données médico-administratives de 1996–1997 à 2009–2010. Des mesures de pression artérielle, de prévalence d’hypertension, de conscience et de contrôle ont été obtenus chez 1 706 Québécois dans les cycles combinés de l’Enquête canadienne sur les mesures de la santé.
RÉSULTATS: En utilisant les données médico-administratives, 23,6 % [Intervalle de confiance à 95%, 23,5–23,6] de la population du Québec (n=1 433 400) âgés de ≥20 ans a été diagnostiqué hypertendue en 2009–2010, ce qui représente une augmentation de 32,1 % comparativement à 2000–2001. L’incidence a diminué de 27,3 %. Parmi les personnes âgées de ≥65 ans, cette prévalence est passée à 69,0 % [IC à 95%, 68,8–69,2] chez les femmes et à 61,7 % [IC à 95%, 61,5–61,9] chez les hommes. Pour les personnes âgées de 20–79 ans, la prévalence de l’hypertension était inférieure avec les données médico-administratives comparativement à celles avec l’enquête (20,2 % et 23,1 %, respectivement). Les niveaux de conscience, traitement et de contrôle étaient de 84,3 %, 83,1 % et 67,9 %, respectivement.
CONCLUSION: La prévalence de l’hypertension provenant des données médico-administratives est comparable à celle obtenue avec une enquête des mesures de la santé. Les femmes âgées (≥65 ans) sont un sous-groupe à risque très élevé. Les niveaux de conscience, de traitement et de contrôle de l’hypertension au Québec sont très élevés.
Mots clés: hypertension, surveillance de la santé publique, tendances, données médico-administratives, données d’enquête
Footnotes
Funding Sources: This research was partly funded by the Public Health Agency of Canada. Dr. Paul Poirier is a senior clinical researcher of the Fonds de recherche en santé du Québec.
Conflict of Interest: None to declare.
References
- 1.World Health Organization. Global health risks: Mortality and burden of disease attributable to selected major risks. Geneva, Switzerland: WHO; 2009. pp. 1–63. [Google Scholar]
- 2.Tremblay E, Guénette L, Gaudet M, Turgeon M. Portrait de l’usage des antihypertenseurs chez les adultes assurés par le régime public d’assurance médicaments du Québec. Québec, QC: Institut national d’excellence en santé et en services sociaux (INESSS); 2012. pp. 1–45. [Google Scholar]
- 3.Robitaille C, Dai S, Waters C, Loukine L, Bancej C, Quach S, Ellison J, Campbell N, Tu K, Reimer K, Walker R, Smith M, Blais C, Quan H. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ. 2012;184:E49. doi: 10.1503/cmaj.101863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Wilkins K, Campbell NR, Joffres MR, McAlister FA, Nichol M, Quach S, Johansen HL, Tremblay MS. Blood pressure in Canadian adults. Health Rep. 2010;21:37. [PubMed] [Google Scholar]
- 5.Atwood KM, Robitaille CJ, Reimer K, Dai S, Johansen HL, Smith MJ. Comparison of diagnosed, self-reported, and physically-measured hypertension in Canada. Can J Cardiol. 2013;29:606. doi: 10.1016/j.cjca.2012.11.019. [DOI] [PubMed] [Google Scholar]
- 6.Health Rep. 2007.
- 7.Campbell NR, Joffres MR, McKay DW. Hypertension surveillance in Canada: minimum standards for assessing blood pressure in surveys. Can J Public Health. 2005;96:217. doi: 10.1007/BF03403694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bryan S, Saint-Pierre Larose M, Campbell N, Clarke J, Tremblay MS. Resting blood pressure and heart rate measurement in the Canadian Healtli Measures Survey, cycle 1. Health Rep. 2010;21:71. [PubMed] [Google Scholar]
- 9.Tu K, Campbell NRC, Chen Z C-D K, McAlister FA. Accuracy of administrative databases in identifying patients with hypertension. Open Medicine. 2007;1:E18. [PMC free article] [PubMed] [Google Scholar]
- 10.Quan H, Khan N, Hemmelgarn BR, Tu K, Chen G, Campbell N, Hill MD, Ghali WA, McAlister FA. Validation of a case definition to define hypertension using administrative data. Hypertension. 2009;54:1423. doi: 10.1161/HYPERTENSIONAHA.109.139279. [DOI] [PubMed] [Google Scholar]
- 11.Crim MT, Yoon SS, Ortiz E, Wall HK, Schober S, Gillespie C, Sorlie P, Keenan N, Labarthe D, Hong Y. National surveillance definitions for hypertension prevalence and control among adults. Circ Cardiovasc Qual Outcomes. 2012;5:343. doi: 10.1161/CIRCOUTCOMES.111.963439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension. 2009;53:480. doi: 10.1161/HYPERTENSIONAHA.108.125617. [DOI] [PubMed] [Google Scholar]
- 13.Cai L, Liu A, Zhang L, Li S, Wang P. Prevalence, awareness, treatment, and control of hypertension among adults in Beijing, China. Clin Exp Hypertens. 2012;34:45. doi: 10.3109/10641963.2011.618206. [DOI] [PubMed] [Google Scholar]
- 14.Kronborg CN, Hallas J, Jacobsen IA. Prevalence, awareness, and control of arterial hypertension in Denmark. J Am Soc Hypertens. 2009;3:19. doi: 10.1016/j.jash.2008.08.001. [DOI] [PubMed] [Google Scholar]
- 15.Gutierrez-Misis A, Sanchez-Santos MT, Banegas JR, Zunzunegui MV, Castell MV, Otero A. Prevalence and incidence of hypertension in a population cohort of people aged 65 years or older in Spain. J Hypertens. 2011;29:1863. doi: 10.1097/HJH.0b013e32834ab497. [DOI] [PubMed] [Google Scholar]
- 16.Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217. doi: 10.1016/S0140-6736(05)70151-3. [DOI] [PubMed] [Google Scholar]
- 17.Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60:599. doi: 10.1016/j.jacc.2012.04.026. [DOI] [PubMed] [Google Scholar]
- 18.Kastarinen M, Antikainen R, Peltonen M, Laatikainen T, Barengo NC, Jula A, Salomaa V, Jousilahti P, Nissinen A, Vartiainen E, Tuomilehto J. Prevalence, awareness and treatment of hypertension in Finland during 1982–2007. J Hypertens. 2009;27:1552. doi: 10.1097/HJH.0b013e32832c41cd. [DOI] [PubMed] [Google Scholar]
- 19.Leenen FH, Dumais J, McInnis NH, Turton P, Stratychuk L, Nemeth K L-K M, Fodor G. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ. 2008;178:1441. doi: 10.1503/cmaj.071340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Gee ME, Campbell NR, Gwadry-Sridhar F, Nolan RP, Kaczorowski J, Bienek A, Robitaille C, Joffres M, Dai S, Walker RL. Antihypertensive medication use, adherence, stops, and starts in Canadians with hypertension. Can J Cardiol. 2012;28:383. doi: 10.1016/j.cjca.2012.01.014. [DOI] [PubMed] [Google Scholar]
- 21.Campbell NR, Chen G. Canadian efforts to prevent and control hypertension. Can J Cardiol. 2010;26(SupplC):14C. doi: 10.1016/S0828-282X(10)71076-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Walker RL, Chen G, Campbell NR, McAlister FA, Quan H, Tu K, Khan NA, Hemmelgarn BR. Canadian provincial trends in antihypertensive drug prescriptions between 1996 and 2006. Can J Cardiol. 2011;27:461. doi: 10.1016/j.cjca.2010.12.071. [DOI] [PubMed] [Google Scholar]
- 23.Gee ME, Bienek A, Campbell NR, Bancej CM, Robitaille C, Kaczorowski J, Joffres M, Dai S G-S F, Nolan RP. Prevalence of, and barriers to, preventive lifestyle behaviors in hypertension (from a national survey of Canadians with hypertension) Am J Cardiol. 2012;109:570. doi: 10.1016/j.amjcard.2011.09.051. [DOI] [PubMed] [Google Scholar]
- 24.Zarnke KB, Campbell NR, McAlister FA, Levine M. A novel process for updating recommendations for managing hypertension: rationale and methods. Can J Cardiol. 2000;16:1094. [PubMed] [Google Scholar]
- 25.McAlister FA. The Canadian Hypertension Education Program—a unique Canadian initiative. Can J Cardiol. 2006;22:559. doi: 10.1016/S0828-282X(06)70277-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Onysko J, Maxwell C, Eliasziw M, Zhang JX, Johansen H, Campbell NR. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. Hypertension. 2006;48:853. doi: 10.1161/01.HYP.0000242335.32890.c6. [DOI] [PubMed] [Google Scholar]
- 27.Campbell NR, Brant R, Johansen H, Walker RL, Wielgosz A, Onysko J, Gao RN, Sambell C, Phillips S, McAlister FA. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension. 2009;53:128. doi: 10.1161/HYPERTENSIONAHA.108.119784. [DOI] [PubMed] [Google Scholar]
- 28.McAlister FA, Feldman RD, Wyard K, Brant R, Campbell NR. The impact of the Canadian Hypertension Education Programme in its first decade. Eur Heart J. 2009;30:1434. doi: 10.1093/eurheartj/ehp192. [DOI] [PubMed] [Google Scholar]
- 29.Bancej CM, Campbell N, McKay DW, Nichol M, Walker RL, Kaczorowski J. Home blood pressure monitoring among Canadian adults with hypertension: results from the 2009 Survey on Living with Chronic Diseases in Canada. Can J Cardiol. 2010;26:e152. doi: 10.1016/S0828-282X(10)70382-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Arima H, Barzi F, Chalmers J. Mortality patterns in hypertension. J Hypertens. 2011;29(Suppl1):S3. doi: 10.1097/01.hjh.0000410246.59221.b1. [DOI] [PubMed] [Google Scholar]
- 31.Gee ME, Janssen I, Pickett W, McAlister FA, Bancej CM, Joffres M, Johansen H, Campbell NR. Prevalence, awareness, treatment, and control of hypertension among Canadian adults with diabetes, 2007 to 2009. Can J Cardiol. 2012;28:367. doi: 10.1016/j.cjca.2011.08.111. [DOI] [PubMed] [Google Scholar]